• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.65% Nasdaq Down 1.89%

    Synergy Pharmaceuticals, Inc. (SGYP)

    -NasdaqGS
    3.01 Down 0.06(1.95%) 4:00PM EST
    |After Hours : 3.01 0.00 (0.00%) 4:50PM EST
    Add to Portfolio
    Prev Close:3.07
    Open:3.06
    Bid:2.40 x 200
    Ask:N/A
    1y Target Est:7.90
    Beta:2.35
    Next Earnings Date:N/A
    Day's Range:2.98 - 3.11
    52wk Range:2.45 - 6.70
    Volume:581,754
    Avg Vol (3m):841,744
    Market Cap:290.79M
    P/E (ttm):N/A
    EPS (ttm):-0.92
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SGYP

    Comparison

    Symbol% ChgMkt Cap
    SGYPDown 1.95%290.79M
    IRWDUp 0.06%2.33B
    SLXPDown 0.55%8.05B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.98
    Quarterly EPS Est (Dec-14) :-0.28
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback